.png){kind=icon}
返回
Efficient budget aware workflow scheduling in cloud using adaptive Tasmanian Devil Optimization algorithm
.png){kind=icon}
PRE
AI
DOI：10.1007/s11042-023-17088-w.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
In order to decrease energy usage in cloud computing, we design the Efficient Budget aware Workflow Scheduling Algorithm (EBWSM) in this study. To achieve this concept, an adaptive Tasmanian Devil Optimization algorithm (ATDO) is developed. The projected ATDO is a combination of Tasmanian Devil Optimization (TDO) and Levy Flight (LF) functions. In the TDO, the position updating process is updated with the assistance of the LF function. The objective function of the cost coefficient factor and energy function is considered for enabling the efficient workflow scheduling model in cloud computing. The efficient pre-suggestion of the available budget is a main key process of this projected method. This workflow scheduling method was created as an effective way to reduce energy consumption while taking the cost coefficient factor and energy into account. This enables equitable allocation of the supplied budget for the cloud workflow application's unscheduled jobs.The proposed method is implemented and compared with the conventional methods of workflow scheduling model. In terms of energy usage, cost function, and makespan, the projected method outperformed the current approaches.
Keyword:
Budget constraints
Workflow scheduling algorithm
Energy function
Cost coefficient factor
Tasmanian devil optimization
Levy flight
期刊
IF:
3
论文数:
2.0W
被引数:
3.2W
机构
引用论文
分享收藏Reliable budget aware workflow scheduling strategy on multi-cloud environment多云环境下可靠的预算感知工作流调度策略
PREAI
分享收藏Abstract 6313: Evaluation of a dual CD123-FLT3 BiTE molecule for acute myeloid leukemia摘要6313：一种双CD123-FLT3 BiTE分子的急性髓系白血病评价
PREAI
分享收藏Cost and makespan aware workflow scheduling in IaaS clouds using hybrid spider monkey optimization
PREAI
分享收藏分享收藏分享收藏Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)安全性、药效学和抗肿瘤活性：SL-172154 作为单药治疗以及与阿扎胞苷 (AZA) 联合治疗在复发/难治性 (R/R) 急性髓系白血病 (AML) 和高风险骨髓增生异常综合征/肿瘤 (HR-MDS) 患者中的研究。.png)
Blood
OAAI
BloodIF0
OAAI分享收藏
查看更多内容